A Phase 1 Open Label, Dose Escalation Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease von Chen, George L., Carpenter, Paul A., Broady, Raewyn, Gregory, Tara B., Arai, Sally, Johnston, Laura, Flowers, Mary E.D., Beumer, Jan H., Mendolsohn, Jodie, Zhou, Xin, Perloff, Spenser H., Otani, Joanne M, Miklos, David B

Volltext